Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children

Sponsor
Yao Yusheng (Other)
Overall Status
Completed
CT.gov ID
NCT01701778
Collaborator
West China Hospital (Other)
90
1
3
15
6

Study Details

Study Description

Brief Summary

The purpose of this study is to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on caudal levobupivacaine analgesia in children undergoing lower abdominal surgeries.

Condition or Disease Intervention/Treatment Phase
  • Drug: Caudal Dexmedetomidine
  • Drug: Intravenous Dexmedetomidine
  • Drug: Placebo
  • Drug: sevoflurane
Phase 2

Detailed Description

Single shot caudal epidural block is one of the most widespread technique for pediatric pain management after infraumbilical surgical procedures.However, in a significant proportion of patients, despite good initial analgesia from a caudal block with local anesthetic, pain develops after the block resolves.

Dexmedetomidine is used increasingly in pediatric anesthesia practice to prolong the duration of action of caudal block with a local anesthetic agent.But which route of administration of clonidine is the most beneficial remains unknown.

The investigators performed prospective randomized double-blind study to compare the effects of caudal dexmedetomidine with intravenous dexmedetomidine on postoperative analgesia after caudal levobupivacaine for inguinal herniorrhaphy or orchidopexy surgery.

90 children (ASAⅠorⅡ,aged 2-5 yr) undergoing unilateral orchiopexy or inguinal herniorrhaphy were included in this study. Anesthesia was induced with sevoflurane via a facemask, followed by placement of a laryngeal mask airway. Anesthesia was maintained with sevoflurane 2-3% in oxygen-air.Then,caudal block was applied. Patients were randomly assigned in three groups. Group Cau-DEX (n = 30): Caudal Levobupivacaine 0.25% 1ml/kg plus dexmedetomidine 1µg/kg and 10 ml normal saline i.v.;Group IV-DEX(n = 30): Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg(10 ml)i.v.;Group Placebo(n = 30): Levobupivacaine 0.25% and 10 ml normal saline intravenous.

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
Double-blind Randomized Controlled Trial of Caudal Versus Intravenous Dexmedetomidine for Supplementation of Caudal Analgesia in Children
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
Jan 1, 2014
Actual Study Completion Date :
Jan 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Experimental: Caudal Dexmedetomidine

Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg Intravenous: 10 ml normal saline Anesthesia was induced and maintained with sevoflurane

Drug: Caudal Dexmedetomidine
Caudal: Levobupivacaine 0.25% 1ml/kg and dexmedetomidine 1µg/kg Intravenous: 10 ml normal saline
Other Names:
  • Precedex
  • Drug: sevoflurane
    Induction and maintain anaesthesia

    Experimental: Intravenous Dexmedetomidine

    Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: dexmedetomidine 1µg/kg Anesthesia was induced and maintained with sevoflurane

    Drug: Intravenous Dexmedetomidine
    Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: dexmedetomidine 1µg/kg
    Other Names:
  • Precedex
  • Drug: sevoflurane
    Induction and maintain anaesthesia

    Placebo Comparator: Placebo

    Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: 10 ml normal saline Anesthesia was induced and maintained with sevoflurane

    Drug: Placebo
    Caudal: Levobupivacaine 0.25% 1ml/kg Intravenous: 10 ml normal saline
    Other Names:
  • Levobupivacaine
  • Drug: sevoflurane
    Induction and maintain anaesthesia

    Outcome Measures

    Primary Outcome Measures

    1. Time to first rescue medication [From the administration of the caudal block to the first registration of a CHIPPS scores≥4,assessed up to 24h]

      the Children and Infants Postoperative Pain Scale (CHIPPS)

    Secondary Outcome Measures

    1. the number of patients not requiring rescue analgesia [After surgery,up to 24h]

      the quality of postoperative pain control

    2. the sedation score [After surgery, every 15min for the first 2 h, every 30min for the next 2h, hourly for the next 4h]

      sedation was assessed using the Modified Ramsay Sedation Score

    3. Residual motor block [After awake,participants will be followed every 30min for the first 2h, hourly for the next 4h]

      the degree of motor blockade was assessed using a modified Bromage scale

    4. the incidence of emergence agitation [Participants will be followed for the duration of PACU stay, an expected average of 2 hours]

      The incidence of emergence agitation was evaluated by the Pediatric Anesthesia Emergence Delirium Scale(PAED)

    5. side effects [From the administration of the caudal block until the end of study period, assessed up to postoperative 24h]

      side effects including bradycardia, hypotension, hypoxemia, nausea, vomiting and urinary retention

    6. Pain intensity [after surgery, 30min for first 4h, hourly for the next 4h and thereafter every 2h,assessed up to 24h]

      Participants will be assessed with Children and Infants Postoperative Pain Scale (CHIPPS)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    2 Years to 5 Years
    Sexes Eligible for Study:
    Male
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • ASA status I-II

    • aged 2-5 yr

    • Undergoing unilateral orchiopexy/inguinal hernia repair

    Exclusion Criteria:
    • Hypersensitivity to any local anesthetics

    • Patient has history of allergy, intolerance, or reaction to dexmedetomidine

    • Infections at puncture sites

    • Bleeding diathesis

    • Preexisting neurological disease

    • Diabetes mellitus

    • Children with uncorrected cardiac lesions

    • Children with heart block or liver impairment

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fujian Provincial Hospital Fuzhou Fujian China 350001

    Sponsors and Collaborators

    • Yao Yusheng
    • West China Hospital

    Investigators

    • Principal Investigator: Yusheng Yao, M.D., Fujian Provincial Hospital
    • Principal Investigator: Yanqing Chen, M.D., Fujian Provicial Hospital
    • Study Director: Jin Liu, M.D., West China Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Yao Yusheng, Double-blind randomized controlled trial of caudal versus intravenous dexmedetomidine for supplementation of caudal analgesia in children, Fujian Provincial Hospital
    ClinicalTrials.gov Identifier:
    NCT01701778
    Other Study ID Numbers:
    • FujianPH
    • FujianPH-TRC-121002
    First Posted:
    Oct 5, 2012
    Last Update Posted:
    Nov 15, 2018
    Last Verified:
    Nov 1, 2018
    Keywords provided by Yao Yusheng, Double-blind randomized controlled trial of caudal versus intravenous dexmedetomidine for supplementation of caudal analgesia in children, Fujian Provincial Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 15, 2018